Stifel Financial’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.1K Buy
+16,633
New +$35.5K ﹤0.01% 3580
2025
Q4
Sell
-23,920
Closed -$40.2K 3650
2025
Q3
$40.2K Sell
23,920
-2,297
-9% -$3.72K ﹤0.01% 3499
2025
Q2
$31.7K Sell
26,217
-1,156
-4% -$1.68K ﹤0.01% 3436
2025
Q1
$34.8K Buy
27,373
+1,512
+6% +$3.95K ﹤0.01% 3371
2024
Q4
$84.1K Sell
25,861
-14,027
-35% -$50.5K ﹤0.01% 3268
2024
Q3
$131K Buy
39,888
+6,578
+20% +$25.6K ﹤0.01% 3206
2024
Q2
$142K Sell
33,310
-2,785
-8% -$27.1K ﹤0.01% 3162
2024
Q1
$531K Sell
36,095
-7,184
-17% -$109K ﹤0.01% 2577
2023
Q4
$416K Buy
43,279
+93
+0.2% +$643 ﹤0.01% 2672
2023
Q3
$201K Sell
43,186
-13,332
-24% -$66.4K ﹤0.01% 2991
2023
Q2
$302K Sell
56,518
-3,656
-6% -$22.6K ﹤0.01% 2819
2023
Q1
$431K Sell
60,174
-371
-0.6% -$2.23K ﹤0.01% 2603
2022
Q4
$406K Sell
60,545
-10,017
-14% -$54.9K ﹤0.01% 2594
2022
Q3
$244K Buy
70,562
+2,143
+3% +$8.2K ﹤0.01% 2846
2022
Q2
$202K Buy
68,419
+24,822
+57% +$130K ﹤0.01% 2996
2022
Q1
$384K Buy
43,597
+8,752
+25% +$96.6K ﹤0.01% 2727
2021
Q4
$559K Sell
34,845
-3,996
-10% -$75.2K ﹤0.01% 2533
2021
Q3
$813K Sell
38,841
-5,224
-12% -$126K ﹤0.01% 2252
2021
Q2
$1.18M Buy
44,065
+15,611
+55% +$457K ﹤0.01% 1971
2021
Q1
$906K Buy
28,454
+7,433
+35% +$181K ﹤0.01% 2056
2020
Q4
$481K Buy
21,021
+1,628
+8% +$37.5K ﹤0.01% 2340
2020
Q3
$489K Sell
19,393
-1,311
-6% -$35.8K ﹤0.01% 2109
2020
Q2
$578K Sell
20,704
-25,246
-55% -$439K ﹤0.01% 1943
2020
Q1
$265K Buy
45,950
+30,091
+190% +$273K ﹤0.01% 2260
2019
Q4
$171K Sell
15,859
-4,428
-22% -$43.8K ﹤0.01% 2806
2019
Q3
$256K Buy
20,287
+950
+5% +$13.7K ﹤0.01% 2524
2019
Q2
$329K Sell
19,337
-17,347
-47% -$298K ﹤0.01% 2450
2019
Q1
$657K Buy
36,684
+18,650
+103% +$322K ﹤0.01% 1900
2018
Q4
$229K Buy
18,034
+2,327
+15% +$39K ﹤0.01% 2390
2018
Q3
$337K Sell
15,707
-22,028
-58% -$470K ﹤0.01% 2292
2018
Q2
$781K Buy
37,735
+17,969
+91% +$405K ﹤0.01% 1781
2018
Q1
$500K Buy
19,766
+3,033
+18% +$73.7K ﹤0.01% 1976
2017
Q4
$315K Buy
16,733
+2,481
+17% +$46.3K ﹤0.01% 2175
2017
Q3
$262K Sell
14,252
-4,436
-24% -$76.8K ﹤0.01% 2227
2017
Q2
$328K Sell
18,688
-1,467
-7% -$28K ﹤0.01% 2086
2017
Q1
$370K Buy
20,155
+1,450
+8% +$28K ﹤0.01% 1986
2016
Q4
$382K Sell
18,705
-2,610
-12% -$65.7K ﹤0.01% 1917
2016
Q3
$635K Buy
21,315
+1,821
+9% +$54.2K ﹤0.01% 1594
2016
Q2
$526K Sell
19,494
-85
-0.4% -$1.92K ﹤0.01% 1731
2016
Q1
$367K Sell
19,579
-3,196
-14% -$60.8K ﹤0.01% 1737
2015
Q4
$706K Buy
22,775
+3,406
+18% +$103K ﹤0.01% 1473
2015
Q3
$415K Buy
19,369
+6,498
+50% +$204K ﹤0.01% 1661
2015
Q2
$489K Sell
12,871
-418
-3% -$13.7K ﹤0.01% 1695
2015
Q1
$417K Buy
13,289
+3,685
+38% +$125K ﹤0.01% 1720
2014
Q4
$337K Sell
9,604
-6,949
-42% -$173K ﹤0.01% 1808
2014
Q3
$346K Buy
16,553
+6,613
+67% +$137K ﹤0.01% 1728
2014
Q2
$216K Buy
+9,940
New +$209K ﹤0.01% 1961

Other funds holding MGNX

Stifel Financial's MGNX Position: Q1 2026 in Review

Stifel Financial opened a new position in MacroGenics (MGNX) in Q1 2026: 16,633 shares worth $48.1K. The stake represents ﹤0.01% of the portfolio and ranks #3580 among its holdings. This is a return to the name: Stifel Financial previously reported a position in MGNX as recently as Q3 2025.

Stifel Financial first reported a position in MGNX in Q2 2014 and has held it in 47 quarters since. The position peaked at $1.18M in Q2 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Stifel Financial held 16,633 shares of MacroGenics worth $48.1K as of Q1 2026.
  • MacroGenics was a new Stifel Financial position in Q1 2026.
  • MacroGenics made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #3580 holding.
  • Stifel Financial first reported a position in MacroGenics in Q2 2014 and has held it in 47 quarters since.
  • Stifel Financial's MacroGenics position peaked at $1.18M in Q2 2021.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.